I am an Imperial College Research Fellow at the MRC Centre for Global Infectious Disease Analysis. I work on mathematical models of infectious diseases, focussed on childhood diseases and the public health impact of new vaccines.
The main focus of my current research is to develop dynamic models for respiratory synctial virus (RSV) transmission and vaccination, to inform target product profiles for RSV vaccine in low-income settings.
I also work on a range of other projects related to estimating the public health impact of the RTS,S/AS01 malaria vaccine and second-generation malaria vaccines in malaria endemic areas.
Before joining the Department of Infectious Disease Epidemiology at Imperial College London, I completed my PhD program at the Research School of Population Health at the Australian National University.
A full list of publications is at www.alexandrahogan.com.
et al., 2020, Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination, Vaccine, ISSN:0264-410X
Campbell P, Geard N, Hogan A, Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting, Bmc Medicine, ISSN:1741-7015
et al., 2020, Potential impact of the COVID-19 pandemic on HIV, TB and malaria in low- and middle-income countries: a modelling study, The Lancet Global Health, Vol:8, ISSN:2214-109X, Pages:e1132-e1141
et al., 2020, The potential public health consequences of COVID-19 on malaria in Africa., Nature Medicine, Vol:26, ISSN:1078-8956, Pages:1411-1416